AI tools to automate medical note-taking are gaining traction. Here's how they are faring in health systems and what challenges lie ahead.
Molly Ferguson for STAT As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm As the technology takes hold, doctors, patients, hospitals, and the companies building these tools are all confronting the same question: When you're ceding control to AI, how good is good enough? Read more. By Brittany Trang |
|
Olivia Obineme for STAT In the whitewashed world of Alzheimer's research, one scientist is on a quest to understand the diversity of brains When she entered the field of Alzheimer's research a quarter century ago, Lisa Barnes was deeply disappointed to find few Black people like her family members with dementia were being studied. A rarity herself — as a Black female cognitive neuropsychologist — she's spent her career quietly pushing back. Read more. By Usha Lee McFarling Mike Reddy for STAT How the drug industry uses fear of fentanyl to extract more profit from naloxone A STAT examination finds that pharmaceutical companies have used the opioid crisis, and the nation's fear of fentanyl, to aggressively market high-cost naloxone products that divert resources away from cheaper forms of the lifesaving medication. Read more. By Lev Facher More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments